Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Scholar Rock Holding Corp
(NQ:
SRRK
)
14.53
+0.57 (+4.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
497,572
Open
14.05
Bid (Size)
14.50 (2)
Ask (Size)
14.53 (40)
Prev. Close
13.96
Today's Range
13.88 - 14.71
52wk Range
5.560 - 21.17
Shares Outstanding
77,866,281
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.
Via
InvestorPlace
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2024
From
Scholar Rock
Via
Business Wire
Performance
YTD
-16.97%
-16.97%
1 Month
-3.13%
-3.13%
3 Month
-2.55%
-2.55%
6 Month
+36.95%
+36.95%
1 Year
+102.37%
+102.37%
More News
Read More
Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst
March 28, 2024
Via
Benzinga
SRRK Stock Earnings: Scholar Rock Holding Misses EPS for Q4 2023
March 19, 2024
Via
InvestorPlace
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
March 19, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2024
From
Scholar Rock, Inc.
Via
Business Wire
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
March 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Scholar Rock to Participate in Upcoming Investor Conferences
February 28, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
February 15, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
February 06, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
January 25, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
January 23, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 12, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Provides Corporate Update and Highlights Priorities for 2024
January 04, 2024
From
Scholar Rock, Inc.
Via
Business Wire
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
January 02, 2024
Via
InvestorPlace
Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
Scholar Rock
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
November 24, 2023
Via
Benzinga
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress
November 07, 2023
From
Scholar Rock, Inc.
Via
Business Wire
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
November 03, 2023
From
Scholar Rock
Via
Business Wire
Earnings Scheduled For November 7, 2023
November 07, 2023
Via
Benzinga
Scholar Rock to Participate in Upcoming Investor Conferences
November 02, 2023
From
Scholar Rock
Via
Business Wire
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.